HPS Pharmacies wish to provide an update on DrugAlert Volume 131 regarding the availability of TIMENTIN (ticarcillin + clavulanate, GSK) 3.1g x 10 vials Aust R 11165.
GlaxoSmithKline Australia has now advised that regular supplies will not be available until February 2013, and wholesaler supplies are expected to be exhausted in three weeks.
Remaining stock will only be released for use on a case-by-case basis where the patient has no alternative treatment options. The small amount HPS Pharmacies retains is currently being used to facilitate the rapid release of TIMENTIN to those approved patients.
HPS Pharmacies is pleased to forward written requests from the prescribing physician to GSK for the release of stock, and to manage receipt and distribution from your local HPS Pharmacy.
TIMENTIN (ticarcillin + clavulanate) vials are indicated for the treatment of serious infections caused by susceptible strains of β-lactamase producing organisms. The Antibiotic Guidelines advise that tazobactam + piperacillin is the only other penicillin with activity against Pseudomonas aeruginosa, advises on alternative therapy for other infections.
Please retain this notice in a prominent position, including other related business units, until supplies return to normal. Should you require further information regarding this matter, please do not hesitate to contact your pharmacist at HPS Pharmacies or GSK Customer Service Department on (03) 9721 8600.
Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.